Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1959 2
1962 4
1963 2
1966 2
1967 2
1968 2
1969 2
1970 3
1971 4
1972 4
1973 7
1974 5
1975 4
1976 6
1977 3
1978 8
1979 8
1980 6
1981 13
1982 12
1983 8
1984 16
1985 20
1986 19
1987 32
1988 14
1989 37
1990 31
1991 33
1992 27
1993 49
1994 48
1995 49
1996 66
1997 57
1998 79
1999 106
2000 132
2001 154
2002 186
2003 204
2004 236
2005 290
2006 309
2007 327
2008 361
2009 374
2010 474
2011 531
2012 623
2013 635
2014 708
2015 744
2016 715
2017 721
2018 768
2019 753
2020 804
2021 853
2022 754
2023 718
2024 170

Text availability

Article attribute

Article type

Publication date

Search Results

11,912 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion.
Oh CJ, Kim MJ, Lee JM, Kim DH, Kim IY, Park S, Kim Y, Lee KB, Lee SH, Lim CW, Kim M, Lee JY, Pagire HS, Pagire SH, Bae MA, Chanda D, Thoudam T, Khang AR, Harris RA, Ahn JH, Jeon JH, Lee IK. Oh CJ, et al. Among authors: kim iy. Kidney Int. 2023 Oct;104(4):724-739. doi: 10.1016/j.kint.2023.06.022. Epub 2023 Jul 1. Kidney Int. 2023. PMID: 37399974
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
Park S, Kim TM, Han JY, Lee GW, Shim BY, Lee YG, Kim SW, Kim IH, Lee S, Kim YJ, Park JH, Park SG, Lee KH, Kang EJ, Kim JW, Shin SH, Ock CY, Nam BH, Lee J, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ. Park S, et al. Among authors: kim ih. J Clin Oncol. 2023 Oct 20:JCO2301891. doi: 10.1200/JCO.23.01891. Online ahead of print. J Clin Oncol. 2023. PMID: 37861993
Integrating genetics and metabolomics from multi-ethnic and multi-fluid data reveals putative mechanisms for age-related macular degeneration.
Han X, Lains I, Li J, Li J, Chen Y, Yu B, Qi Q, Boerwinkle E, Kaplan R, Thyagarajan B, Daviglus M, Joslin CE, Cai J, Guasch-Ferré M, Tobias DK, Rimm E, Ascherio A, Costenbader K, Karlson E, Mucci L, Eliassen AH, Zeleznik O, Miller J, Vavvas DG, Kim IK, Silva R, Miller J, Hu F, Willett W, Lasky-Su J, Kraft P, Richards JB, MacGregor S, Husain D, Liang L. Han X, et al. Among authors: kim ik. Cell Rep Med. 2023 Jul 18;4(7):101085. doi: 10.1016/j.xcrm.2023.101085. Epub 2023 Jun 21. Cell Rep Med. 2023. PMID: 37348500 Free PMC article.
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer.
Sung C, An J, Lee S, Park J, Lee KS, Kim IH, Han JY, Park YH, Kim JH, Kang EJ, Hong MH, Kim TY, Lee JC, Lee JL, Yoon S, Choi CM, Lee DH, Yoo C, Kim SW, Jeong JH, Seo S, Kim SY, Kong SY, Choi JK, Park SR. Sung C, et al. Among authors: kim ih. Nat Cancer. 2023 Jun;4(6):844-859. doi: 10.1038/s43018-023-00572-5. Epub 2023 Jun 12. Nat Cancer. 2023. PMID: 37308678
Extracellular Vesicles for Muscle Atrophy Treatment.
Su X, Shen Y, Kim IM, Weintraub NL, Hamrick M, Tang Y. Su X, et al. Among authors: kim im. Adv Exp Med Biol. 2023;1418:119-126. doi: 10.1007/978-981-99-1443-2_8. Adv Exp Med Biol. 2023. PMID: 37603276 Review.
Who Can Stop This Fire?
Lee HJ, Kim IC. Lee HJ, et al. Among authors: kim ic. Korean Circ J. 2023 Dec;53(12):811-812. doi: 10.4070/kcj.2023.0289. Korean Circ J. 2023. PMID: 38111260 Free PMC article. No abstract available.
Incorporating ecology into gene drive modelling.
Kim J, Harris KD, Kim IK, Shemesh S, Messer PW, Greenbaum G. Kim J, et al. Among authors: kim ik. Ecol Lett. 2023 Sep;26 Suppl 1:S62-S80. doi: 10.1111/ele.14194. Ecol Lett. 2023. PMID: 37840022 Review.
A systems biology approach uncovers novel disease mechanisms in age-related macular degeneration.
Orozco LD, Owen LA, Hofmann J, Stockwell AD, Tao J, Haller S, Mukundan VT, Clarke C, Lund J, Sridhar A, Mayba O, Barr JL, Zavala RA, Graves EC, Zhang C, Husami N, Finley R, Au E, Lillvis JH, Farkas MH, Shakoor A, Sherva R, Kim IK, Kaminker JS, Townsend MJ, Farrer LA, Yaspan BL, Chen HH, DeAngelis MM. Orozco LD, et al. Among authors: kim ik. Cell Genom. 2023 Apr 18;3(6):100302. doi: 10.1016/j.xgen.2023.100302. eCollection 2023 Jun 14. Cell Genom. 2023. PMID: 37388919 Free PMC article.
Constraints on the Decay of ^{180m}Ta.
Arnquist IJ, Avignone FT, Barabash AS, Barton CJ, Bhimani KH, Blalock E, Bos B, Busch M, Buuck M, Caldwell TS, Christofferson CD, Chu PH, Clark ML, Cuesta C, Detwiler JA, Efremenko Y, Ejiri H, Elliott SR, Giovanetti GK, Goett J, Green MP, Gruszko J, Guinn IS, Guiseppe VE, Haufe CR, Henning R, Hervas Aguilar D, Hoppe EW, Hostiuc A, Kim I, Kouzes RT, Lannen V TE, Li A, López-Castaño JM, Massarczyk R, Meijer SJ, Meijer W, Oli TK, Paudel LS, Pettus W, Poon AWP, Radford DC, Reine AL, Rielage K, Rouyer A, Ruof NW, Schaper DC, Schleich SJ, Smith-Gandy TA, Tedeschi D, Thompson JD, Varner RL, Vasilyev S, Watkins SL, Wilkerson JF, Wiseman C, Xu W, Yu CH; <span class="sc">Majorana</span> <span class="sc">Collaboration</span>; Alves DSM, Hebenstiel L, Ramani H. Arnquist IJ, et al. Among authors: kim i. Phys Rev Lett. 2023 Oct 13;131(15):152501. doi: 10.1103/PhysRevLett.131.152501. Phys Rev Lett. 2023. PMID: 37897780
11,912 results
You have reached the last available page of results. Please see the User Guide for more information.